A new Nature Reviews Urology review warns that intraductal and invasive cribriform prostate cancers are aggressive, genomically unstable and frequently missed on biopsy, with major consequences for ...
For patients with BCG-unresponsive non-muscle-invasive bladder cancer, bladder-preserving therapies are emerging as alternatives to radical cystectomy. This Review examines the biological rationale ...
Continuous Decipher score was associated with development of unfavorable histology following CAPRA adjustment (HR, 3.68). A high Decipher genomic risk score is associated with greater risk for major ...
A single patient with one of the rarest and most aggressive salivary gland malignancies has provided oncologists with an unexpected glimpse of what may become a new therapeutic avenue for tumors that ...
Why do some prostate cancers grow slowly for years, while others progress quickly to life-threatening metastatic disease? An ...
Adam B. WeinerÖ‰ Cribriform and Intraductal Carcinoma Identified as High-Risk Histological Forms of Prostate Cancer / Adam B.
Prostate Cancer Trials to Watch at ESMO 2026 / cancer, cancer care, Cancer research, cancer treatment, Castration-Resistant ...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, ...
Many treatments for prostate cancer, one of the most common cancers in men, target a protein called the androgen receptor, ...
Adding the targeted radioactive drug 177Lu-PNT2002 to stereotactic body radiation therapy, or SBRT, may help keep recurrent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results